Beta-blockers for hyperthyreoidism
In a double-blind, cross-over and placebo-controlled study seven patients were given carbimazole plus either placebo or propranolol (40 mg) for 1 month and then switched to the alternative adjunct treatment for a further month
To continue reading this article, you must log in with your personal, organization, or group practice subscription. For more information or to purchase a personal subscription, click below to see pricing.
Do you want to read more?